TRPV1-targeted drugs in development for human pain conditions

M Iftinca, M Defaye, C Altier - Drugs, 2021 - Springer
The transient receptor potential vanilloid-1 (TRPV1) is a non-specific cation channel known
for its sensitivity to pungent vanilloid compound (ie capsaicin) and noxious stimuli, including …
被引用次数：114 相关文章

TRPV1‑Targeted Drugs in Development for Human Pain Conditions

M Iftinca, M Defaye, C Altier - Drugs, 2021 - search.proquest.com
The transient receptor potential vanilloid-1 (TRPV1) is a non-specific cation channel known
for its sensitivity to pungent vanilloid compound (ie capsaicin) and noxious stimuli, including …

TRPV1-Targeted Drugs in Development for Human Pain Conditions

M Iftinca, M Defaye, C Altier - Drugs, 2021 - pubmed.ncbi.nlm.nih.gov
The transient receptor potential vanilloid-1 (TRPV1) is a non-specific cation channel known
for its sensitivity to pungent vanilloid compound (ie capsaicin) and noxious stimuli, including …

[引用][C] TRPV1-Targeted Drugs in Development for Human Pain Conditions

M Iftinca, M Defaye, C Altier - Drugs, 2020 - cir.nii.ac.jp
TRPV1-Targeted Drugs in Development for Human Pain Conditions | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

TRPV1-Targeted Drugs in Development for Human Pain Conditions.

M Iftinca, M Defaye, C Altier - Drugs, 2021 - search.ebscohost.com
The transient receptor potential vanilloid-1 (TRPV1) is a non-specific cation channel known
for its sensitivity to pungent vanilloid compound (ie capsaicin) and noxious stimuli, including …

TRPV1-Targeted Drugs in Development for Human Pain Conditions.

M Iftinca, M Defaye, C Altier - Drugs, 2021 - europepmc.org
The transient receptor potential vanilloid-1 (TRPV1) is a non-specific cation channel known
for its sensitivity to pungent vanilloid compound (ie capsaicin) and noxious stimuli, including …